Fonte: Clinical Microbiology and Infection. Unidade: FCFRP
Assuntos: COVID-19, UNIDADES DE TERAPIA INTENSIVA, DOENÇA PULMONAR (ESPECIALIDADE), DOENÇAS INFECCIOSAS, FUNGOS, MICOLOGIA MÉDICA
ABNT
PRATTES, Juergen et al. Risk factors and outcome of pulmonary aspergillosis in critically ill coronavirus disease 2019 patients - a multinational observational study by the European Confederation of Medical Mycology. Clinical Microbiology and Infection, v. 28, n. 4, p. 580-587, 2022Tradução . . Disponível em: https://doi.org/10.1016/j.cmi.2021.08.014. Acesso em: 02 dez. 2025.APA
Prattes, J., Wauters, J., Giacobbe, D. R., Salmanton-García, J., Maertens, J., Bourgeois, M., et al. (2022). Risk factors and outcome of pulmonary aspergillosis in critically ill coronavirus disease 2019 patients - a multinational observational study by the European Confederation of Medical Mycology. Clinical Microbiology and Infection, 28( 4), 580-587. doi:10.1016/j.cmi.2021.08.014NLM
Prattes J, Wauters J, Giacobbe DR, Salmanton-García J, Maertens J, Bourgeois M, Reynders M, Rutsaert L, Van Regenmortel N, Lormans P, Goldman GH. Risk factors and outcome of pulmonary aspergillosis in critically ill coronavirus disease 2019 patients - a multinational observational study by the European Confederation of Medical Mycology [Internet]. Clinical Microbiology and Infection. 2022 ; 28( 4): 580-587.[citado 2025 dez. 02 ] Available from: https://doi.org/10.1016/j.cmi.2021.08.014Vancouver
Prattes J, Wauters J, Giacobbe DR, Salmanton-García J, Maertens J, Bourgeois M, Reynders M, Rutsaert L, Van Regenmortel N, Lormans P, Goldman GH. Risk factors and outcome of pulmonary aspergillosis in critically ill coronavirus disease 2019 patients - a multinational observational study by the European Confederation of Medical Mycology [Internet]. Clinical Microbiology and Infection. 2022 ; 28( 4): 580-587.[citado 2025 dez. 02 ] Available from: https://doi.org/10.1016/j.cmi.2021.08.014
